*001905741
*00520240611121138.0
*007ta
*008110106d19901993no gr p           a0eng
*00901622cas a2200409 c 4500
*019  $bjp
*0220 $a0802-8753$2r
*035  $a(EXLNZ-47BIBSYS_NETWORK)999114458034702201
*035  $a(NO-LaBS)36813853(bibid)
*035  $a(NO-TrBIB)911445803
*035  $a911445803-47bibsys_network
*040  $aNO-OsNB$bnob$ekatreg
*044  $cno
*060 4$aW 1
*080  $a615(03)
*080  $a615.11(05)
*08274$a615.1$qNO-OsNB$24/nor
*2101 $aGuidel. ATC class.
*222 0$aGuidelines for ATC classification
*24500$aGuidelines for ATC classification :$ba co-publication between: WHO Collaborating Centre for Drug Statistics Methodology, Nordic Council on Medicines
*260  $aOslo$bWHO Collaborating Centre for Drug Statistics Methodology$c[1990]-1993
*310  $aÅrlig
*3620 $a[1990]-ed. 4 (1993)
*500  $aTidligere utgiversted: Uppsala
*515  $aIkke utgitt: 1991-1992 (?)
*550  $aTidligere medutgiver: Nordiska läkemedelsnämnden
*580  $aSlått sammen med: Guidelines for DDD, 2(1993) til: Guidelines for ATC classification and DDD assignment ..., 1(1996)
*650 2$aPharmacology$_13842600
*650 7$aLegemidler$2tekord$9nob$vHåndbøker$_187904000
*7102 $aNordiska läkemedelsnämnden$0(NO-TrBIB)90269111$4pbl$_44308200
*7102 $aWHO Collaborating Centre for Drug Statistics Methodology$0(NO-TrBIB)90269110$4pbl$_45720300
*78517$tGuidelines for ATC classification and DDD assignment ...$g1(1996)$w990301162604702201$x1726-4898
*78517$tGuidelines for DDD$g2(1993)$w999114458704702201$x0803-2971
*86630$a[1990], 4(1993)$90183300$822108234880002202
*901  $a80
*913  $aNorper$bNB
*991  $avolumes$_10052300
*999  $aoai:nb.bibsys.no:999114458034702202$b2021-11-14T20:58:23Z$z999114458034702202
^